FDA.reportPublic FDA data

0.5 ML Amvuttra 50 MG/ML Prefilled Syringe

RxCUI
2604794
RxNorm name
0.5 ML Amvuttra 50 MG/ML Prefilled Syringe
Display name
0.5 ML Amvuttra 50 MG/ML Prefilled Syringe
Full name
0.5 ML Amvuttra 50 MG/ML Prefilled Syringe
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AMVUTTRAVUTRISIRANAlnylam Pharmaceuticals, Inc.8db0facb-81b6-4006-9239-27dc6409c5d32025-11-06Warnings, Adverse reactionsExact identifier
rxcui: 2604794

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
8db0facb-81b6-4006-9239-27dc6409c5d30.5 ML Amvuttra 50 MG/ML Prefilled SyringeSY8These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 202220251106
8db0facb-81b6-4006-9239-27dc6409c5d3amvuttra 25 MG in 0.5 ML Prefilled SyringePSN8These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 202220251106
8db0facb-81b6-4006-9239-27dc6409c5d30.5 ML vutrisiran 50 MG/ML Prefilled Syringe [Amvuttra]SBD8These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 202220251106
8db0facb-81b6-4006-9239-27dc6409c5d3Amvuttra 25 MG per 0.5 ML Prefilled SyringeSY8These highlights do not include all the information needed to use AMVUTTRA ® safely and effectively. See full prescribing information for AMVUTTRA. AMVUTTRA (vutrisiran) injection, for subcutaneous use Initial U.S. Approval: 202220251106